J

Japan Tissue Engineering Co Ltd
TSE:7774

Watchlist Manager
Japan Tissue Engineering Co Ltd
TSE:7774
Watchlist
Price: 435 JPY -3.33% Market Closed
Market Cap: 17.7B JPY
Have any thoughts about
Japan Tissue Engineering Co Ltd?
Write Note

Japan Tissue Engineering Co Ltd
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Japan Tissue Engineering Co Ltd
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
J
Japan Tissue Engineering Co Ltd
TSE:7774
Total Current Assets
ÂĄ4.9B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
12%
GNI Group Ltd
TSE:2160
Total Current Assets
ÂĄ27.3B
CAGR 3-Years
14%
CAGR 5-Years
21%
CAGR 10-Years
18%
PeptiDream Inc
TSE:4587
Total Current Assets
ÂĄ58.9B
CAGR 3-Years
57%
CAGR 5-Years
46%
CAGR 10-Years
26%
Takara Bio Inc
TSE:4974
Total Current Assets
ÂĄ63.8B
CAGR 3-Years
3%
CAGR 5-Years
13%
CAGR 10-Years
5%
Pharma Foods International Co Ltd
TSE:2929
Total Current Assets
ÂĄ23.8B
CAGR 3-Years
2%
CAGR 5-Years
29%
CAGR 10-Years
26%
C
Cuorips Inc
TSE:4894
Total Current Assets
ÂĄ5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Japan Tissue Engineering Co Ltd
Glance View

Market Cap
17.7B JPY
Industry
Biotechnology

Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. The company is headquartered in Gamagori-Shi, Aichi-Ken and currently employs 200 full-time employees. The company went IPO on 2007-12-21. The firm operates its business in two segments. The TEP segment is engaged in the research and development of self-cultured epidermis, self-cultured cartilages and self-cultured corneal epithelium for medical institutions. The Research and Development Supports segment is engaged in the development, manufacture and sale of laboratory human cultured tissues based on tissue engineering technology and manufacturing know-how for cosmetic and pharmaceutical product manufacturers.

Intrinsic Value
376.39 JPY
Overvaluation 13%
Intrinsic Value
Price
J

See Also

What is Japan Tissue Engineering Co Ltd's Total Current Assets?
Total Current Assets
4.9B JPY

Based on the financial report for Sep 30, 2024, Japan Tissue Engineering Co Ltd's Total Current Assets amounts to 4.9B JPY.

What is Japan Tissue Engineering Co Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
12%

Over the last year, the Total Current Assets growth was -5%. The average annual Total Current Assets growth rates for Japan Tissue Engineering Co Ltd have been -7% over the past three years , -6% over the past five years , and 12% over the past ten years .

Back to Top